{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:38:15Z","timestamp":1767973095430,"version":"3.49.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Background and Purpose\u2014<\/jats:title>\n            <jats:p>Stroke is a leading cause of disability worldwide, mainly affecting the elderly. However, preclinical studies in aged ischemic animals are limited. N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) is a naturally occurring tetrapeptide with vascular-protective properties. The present study investigated the effect of AcSDKP on tPA (tissue-type plasminogen activator)-induced thrombolysis in aged rats after ischemic stroke.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\u2014<\/jats:title>\n            <jats:p>Aged male rats (18 months) were subjected to embolic middle cerebral artery occlusion. Rats subjected to 4 hours of middle cerebral artery occlusion were randomized into the following groups: (1) AcSDKP; (2) tPA; (3) AcSDKP in combination with tPA; and (4) saline. Neurological deficits, cerebral microvascular patency and integrity, and infarction were examined at 1 day and 7 days after middle cerebral artery occlusion. In vitro experiments were performed to examine the effect of AcSDKP on aged cerebral endothelial cell permeability.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results\u2014<\/jats:title>\n            <jats:p>Compared with saline, AcSDKP, or tPA as monotherapy did not have any therapeutic effects, whereas AcSDKP in combination with tPA significantly reduced cerebral tissue infarction and improved neurological outcome without increasing cerebral hemorrhage. Concurrently, the combination treatment significantly augmented microvascular perfusion and reduced thrombosis and blood-brain barrier leakage. In vitro, compared with cerebral endothelial cells from ischemic adult rats, the endothelial cells from ischemic aged rats exhibited significantly increased leakage. AcSDKP suppressed tPA-induced aged endothelial cell leakage and reduced expression of ICAM-1 (intercellular adhesion molecule 1) and NF (nuclear factor)-\u03baB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions\u2014<\/jats:title>\n            <jats:p>The present study provides evidence for the therapeutic efficacy of AcSDKP in combination tPA for the treatment of embolic stroke in aged rats at 4 hours after stroke onset. AcSDKP likely acts on cerebral endothelial cells to enhance the benefits of tPA by increasing tissue perfusion and augmenting the integrity of the blood-brain barrier.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Visual Overview\u2014<\/jats:title>\n            <jats:p>\n              An online\n              <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"visual overview\">visual overview<\/jats:ext-link>\n              is available for this article.\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/strokeaha.119.026212","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T09:00:23Z","timestamp":1565168423000},"page":"2547-2554","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Augments Thrombolysis of tPA (Tissue-Type Plasminogen Activator) in Aged Rats After Stroke"],"prefix":"10.1161","volume":"50","author":[{"given":"Chao","family":"Li","sequence":"first","affiliation":[{"name":"From the Department of Neurology, Henry Ford Hospital, Detroit, MI (C.L., L.Z., C.W., H.T., B.F., M.C., Z.G.Z.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Henry Ford Hospital, Detroit, MI (C.L., L.Z., C.W., H.T., B.F., M.C., Z.G.Z.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyang","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Henry Ford Hospital, Detroit, MI (C.L., L.Z., C.W., H.T., B.F., M.C., Z.G.Z.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Teng","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Henry Ford Hospital, Detroit, MI (C.L., L.Z., C.W., H.T., B.F., M.C., Z.G.Z.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoyan","family":"Fan","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Henry Ford Hospital, Detroit, MI (C.L., L.Z., C.W., H.T., B.F., M.C., Z.G.Z.)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Chopp","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Henry Ford Hospital, Detroit, MI (C.L., L.Z., C.W., H.T., B.F., M.C., Z.G.Z.)"},{"name":"Department of Physics, Oakland University, Rochester, MI (M.C.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng Gang","family":"Zhang","sequence":"additional","affiliation":[{"name":"From the Department of Neurology, Henry Ford Hospital, Detroit, MI (C.L., L.Z., C.W., H.T., B.F., M.C., Z.G.Z.)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.36"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9185.150530"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00163-X"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.01.007"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4949.2009.00292.x"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.544395"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2009.105"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.06.012"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.006551"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.144568"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00481.2008"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00776.2006"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118484"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.30.5.1015"},{"key":"e_1_3_4_16_2","first-page":"1257","article-title":"In vivo assessment of captopril selectivity of angiotensin I-converting enzyme inhibition: differential inhibition of acetyl-ser-asp-lys-pro and angiotensin I hydrolysis.","volume":"289","author":"Junot C","year":"1999","unstructured":"Junot, C, Menard, J, Gonzales, MF, Michaud, A, Corvol, P, Ezan, E. In vivo assessment of captopril selectivity of angiotensin I-converting enzyme inhibition: differential inhibition of acetyl-ser-asp-lys-pro and angiotensin I hydrolysis. J Pharmacol Exp Ther. 1999;289:1257\u20131261.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.004399"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1161\/STROKEAHA.116.013578","article-title":"Stroke treatment academic industry roundtable.","volume":"47","author":"Jovin Tudor G","year":"2016","unstructured":"Jovin Tudor, G, Albers Gregory, W, Liebeskind David, S; STAIR IX Consortium. Stroke treatment academic industry roundtable. Stroke. 2016;47:2656\u20132665.","journal-title":"Stroke"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(97)00580-5"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2009.279"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003851"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.01.003"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(88)90226-9"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/hs1101.098367"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199901000-00008"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000068374.57764.EB"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.STR.30.3.624","article-title":"Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain.","volume":"30","author":"Zhang RL","year":"1999","unstructured":"Zhang, RL, Zhang, ZG, Chopp, M, Zivin, JA. Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain. Stroke. 1999;30:624\u2013629.","journal-title":"Stroke"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600573"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142725"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/2211068214561025"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2012.06.057"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2018.13"},{"key":"e_1_3_4_33_2","first-page":"869","article-title":"Effects of sodium beta-aescin on expression of adhesion molecules and migration of neutrophils after middle cerebral artery occlusion in rats.","volume":"25","author":"Hu XM","year":"2004","unstructured":"Hu, XM, Zhang, Y, Zeng, FD. Effects of sodium beta-aescin on expression of adhesion molecules and migration of neutrophils after middle cerebral artery occlusion in rats. Acta Pharmacol Sin. 2004;25:869\u2013875.","journal-title":"Acta Pharmacol Sin"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.02.006"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.15.1831"},{"key":"e_1_3_4_36_2","first-page":"1581","article-title":"The national institute of neurological disorders and stroke rt-pa stroke study group.","volume":"333","author":"Tissue plasminogen activator for acute ischemic stroke","year":"1995","unstructured":"Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-pa stroke study group. N Engl J Med. 1995;333:1581\u20131587.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X18798162"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000158923.19956.73"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.252619"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00592.2004"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.252619"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.036"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.309278"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24528"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00054-X"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx126"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.13647"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.020273"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0869-8"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.568766"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13122327"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2014.04.025"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002982"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1537-1891(02)00199-4"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00085"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2018.1484100"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1415.033"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.119.026212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T15:12:50Z","timestamp":1715613170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.119.026212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1161\/STROKEAHA.119.026212"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.119.026212","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"2019-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}